Yanyan Wang

Yanyan Wang began their work experience at Brigham and Women's Hospital in 2003 as a Research Associate. During their time there, they played a major role in various research projects related to NF-κB transcription factors and innate inflammatory responses. Yanyan also made significant contributions to research on the development of colitis and the gene expression patterns in acute appendicitis patients.

In 2011, Yanyan moved to the Dana-Farber Cancer Institute and worked as a Research Technician Lead until 2012. Yanyan then joined the Massachusetts General Hospital in 2013 as a Research Technician II, where they worked until 2014.

Yanyan joined Enumeral Biomedical Corp in 2015 as a Principal Research Associate, where they worked until 2016. Yanyan then became an Associate Scientist at EMD Serono, Inc in September 2016 and worked there until January 2022.

Currently, Yanyan is employed at Adept Therapeutics Inc as a Scientist, starting in January 2022.

Yanyan Wang obtained their M.D. in Clinical Medicine from Dalian Medical University, where they attended from 1993 to 1998.